| Research Topics: |
| INDEX |
| AI-chat 1 |
| PRIME 11 |
| aging 12 |
| body 1 |
| brain 14 |
| brainwave 1 |
| cancer 11 |
| climate 1 |
| cognition 4 |
| covid-19 2 |
| culture 6 |
| dental 6 |
| diabetes 9 |
| disease 1 |
| emergency 1 |
| energy 1 |
| eyes 1 |
| genetics 4 |
| gut 2 |
| heart 8 |
| herbs 1 |
| immune 2 |
| kidneys 3 |
| lungs 2 |
| metabolism 3 |
| microbiome 4 |
| nutrition 6 |
| obesity 3 |
| pain 1 |
| politics 4 |
| pollution 4 |
| psychology 9 |
| radiation 1 |
| religion 1 |
| rights 1 |
| unk |
| virus 3 |
| war-confl |
|
Scanned: 1397 Evaluated: 447 Selected: 78 |
| COVID-19 IMMUNE VIRUS | ||||||||
Mbr17-014 | Comparative LUSZ Therapeutic Study (LUSZ_AVIST) of Antiviral, Antiretroviral, and Immunosuppressive Treatments in Hospitalized COVID-19 Patients with High-Risk Factors, Biomarkers, and Disease Progression | |||||||
| Quote: | We succeeded to establish a novel predictive scoring model of disease progression based on a cohort of Lebanese hospitalized patients relying on the pulmonary inflammatory lesions, inflammation biomarkers such as LDH, D-Dimer, CRP, IL-6 and the lymphocyte count, the number of comorbidities and the age of the patient which all were significantly correlated with the illness severity showing best outcomes with immunomodulatory and anticoagulant treatments by the results. As top tier, Tocilizumab was more efficient than the two other treatments in non-severe cases but none of the used treatments was insanely effective alone to reduce mortality in severe cases. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.04.10.26350587v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.04.10.26350587v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Elisa Makdessi Fadi Fenianos Nadine Nasreddine Wissame Daher Samar El-Hamoui Nehman Makdissy, | |||||||
| COVID-19 PSYCHOLOGY | ||||||||
Mpc17-002 | Disentangling Fatigue from Depression among Survivors of Severe COVID-19 | |||||||
| Quote: | We found that the presence of fatigue inflated depression severity through symptoms of tiredness and difficulty sleeping, which are two of the nine items of a commonly used depression screening tool, known as the Patient Health Questionnaire-9 (PHQ-9). Depression screening tools that omit these two items, such as the PHQ-2, may better screen for depressive symptoms in PICS, minimizing the risk of overestimating depression symptoms and potentially misdiagnosis. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.04.24.26351694v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.04.24.26351694v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Juan R. Cabrera Peter Pham W. John Boscardin Anil N. Makam, | |||||||
|
Javilk's Research Links for Week 17 Updated 05/02/2026-01:34:02 AM What interests you? What have you found? Tell me! Drop me a note to subscribe or submit something. |